EUVIMEDEUVIMED entdecken
Crossref

Oncogene Expression and Prognosis in Epithelial Ovarian Cancer: A TCGA-Based Study

Letícia Nunes Benevides, Carlos Alberto Barbosa Neto, Fabrícia Cardoso Marques, Nathalia Ferreira Lima Amaral, Eduardo Araújo Costa Lima, Maria Eduarda Medeiros Nunes, Abel Caminha Barreto Neto, Júlia Menezes Gifoni, Cecília Dias Caminha Gentile, Júlia Matos Dubanhevitz, Markus Andret Cavalcante Gifoni

Brazilian Journal of Oncology · 26.06.2026 · 22 (CP)

DOI: 10.1055/s-0046-1825396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brazilian Journal of Oncology, erschienen am 26.06.2026. Verfasst von Letícia Nunes Benevides und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

All articles of this category (opens in new window) Address for correspondence Letícia Nunes Benevides (leticianunesb@alu.ufc.br)

Introduction

Epithelial ovarian cancer is characterized by significant molecular heterogeneity, with various oncogenic alterations driving proliferation, angiogenesis, and therapeutic resistance. The identification of mutations and amplifications in key genes has enabled the development of promising targeted therapies such as alpelisib, trastuzumab, and sunitinib. In this context, genomic profiling becomes essential for risk stratification and personalized treatment in ovarian cancer .

Methods

Oncogenes associated with epitelial ovarian cancer were selected from The Cancer Genome Atlas (TCGA) database. Genomic alterations, somatic mutation frequency and overall survival (OS) data were obtained from public datasets available through the cBioPortal platform. A total of 311 samples were stratified into two groups: “altered,” defined by at least one alteration in any of the 17 selected genes, and “unaltered”, with no detected alterations. OS differences between groups were assessed using Kaplan-Meier survival curves and the log-rank test via the UALCAN platform.

Objectives

To assess the prognostic and predictive significance of the oncogenes pathway gene in ovarian cancer through genomic profiling .

Results

Among the 311 samples, 267 (86%) exhibited alterations in at least one relevant oncogenes pathway gene. The most frequently altered genes were MYC (41%), MECOM (34%), PRKCI (32%), EIF5A2 (31%), PIK3CA (29%), and CCNE1 (22%). 31 mutations were identified (28 missense, two truncating and one splice). Considering the ovarian serous cystadenocarcinoma, patients with high expression of MYC (p=0,044), KIT (p=0,043), AKT1 (p=0,042), CCNE1 (p=0,033), and AKT2 (p=0,041). demonstrated significantly longer OS compared with those with low or intermediate expression levels. Although patients in the “unaltered” group had poorer OS compared with the “altered” group, the difference did not reach statistical significance (p=0,270) .

Conclusion

Oncogenic pathway signaling plays a crucial role in prognosis and therapeutic response in epithelial ovarian cancer, reinforcing the importance of targeted treatment approaches. These observations emphasize the need for further studies to clarify these mechanisms and improve therapeutic strategies. Publication History Article published online: 26 June 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil Bibliographical Record Letícia Nunes Benevides, Carlos Alberto Barbosa Neto, Fabrícia Cardoso Marques, Nathalia Ferreira Lima Amaral, Eduardo Araújo Costa Lima, Maria Eduarda Medeiros Nunes, Abel Caminha Barreto Neto, Júlia Menezes Gifoni, Cecília Dias Caminha Gentile, Júlia Matos Dubanhevitz, Markus Andret Cavalcante Gifoni. Oncogene Expression and Prognosis in Epithelial Ovarian Cancer: A TCGA-Based Study. Brazilian Journal of Oncology 2026; 22. DOI: 10.1055/s-0046-1825396

Zitieren

APA

Benevides, L. N., Neto, C. A. B., Marques, F. C., Amaral, N. F. L., Lima, E. A. C., Nunes, M. E. M., Neto, A. C. B., Gifoni, J. M., Gentile, C. D. C., Dubanhevitz, J. M., & Gifoni, M. A. C. (2026). Oncogene Expression and Prognosis in Epithelial Ovarian Cancer: A TCGA-Based Study. Brazilian Journal of Oncology, 22(CP). https://doi.org/10.1055/s-0046-1825396

Vancouver

Benevides LN, Neto CAB, Marques FC, Amaral NFL, Lima EAC, Nunes MEM, et al. Oncogene Expression and Prognosis in Epithelial Ovarian Cancer: A TCGA-Based Study. Brazilian Journal of Oncology. 2026;22(CP). doi:10.1055/s-0046-1825396

BibTeX
@article{Benevides2026,
  author = {Benevides, Letícia Nunes and Neto, Carlos Alberto Barbosa and Marques, Fabrícia Cardoso and Amaral, Nathalia Ferreira Lima and Lima, Eduardo Araújo Costa and Nunes, Maria Eduarda Medeiros and Neto, Abel Caminha Barreto and Gifoni, Júlia Menezes and Gentile, Cecília Dias Caminha and Dubanhevitz, Júlia Matos and Gifoni, Markus Andret Cavalcante},
  title = {Oncogene Expression and Prognosis in Epithelial Ovarian Cancer: A TCGA-Based Study},
  journal = {Brazilian Journal of Oncology},
  year = {2026},
  volume = {22},
  number = {CP},
  doi = {10.1055/s-0046-1825396}
}
Kostenlos starten →